X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
abridged index medicus (2) 2
adult (2) 2
aged (2) 2
anti-retroviral agents - adverse effects (2) 2
anti-retroviral agents - therapeutic use (2) 2
care and treatment (2) 2
ccr5 receptor antagonists (2) 2
cd4 lymphocyte count (2) 2
cyclohexanes - adverse effects (2) 2
cyclohexanes - therapeutic use (2) 2
double-blind method (2) 2
drug resistance (2) 2
drug therapy (2) 2
drug therapy, combination (2) 2
efficacy (2) 2
female (2) 2
health aspects (2) 2
hiv fusion inhibitors - adverse effects (2) 2
hiv fusion inhibitors - therapeutic use (2) 2
hiv infection (2) 2
hiv infections - drug therapy (2) 2
hiv infections - virology (2) 2
hiv-1 - chemistry (2) 2
hiv-1 - genetics (2) 2
human immunodeficiency virus--hiv (2) 2
humans (2) 2
index medicus (2) 2
male (2) 2
maraviroc (2) 2
medicine, general & internal (2) 2
middle aged (2) 2
rna, viral - blood (2) 2
triazoles - adverse effects (2) 2
triazoles - therapeutic use (2) 2
viral load (2) 2
active antiretroviral therapy (1) 1
antiretroviral drugs (1) 1
antiretroviral therapy (1) 1
antiviral agents (1) 1
article (1) 1
ccr5 antagonist (1) 1
ccr5 inhibitor (1) 1
chemokines (1) 1
clinical-trials (1) 1
comparative analysis (1) 1
coreceptor use (1) 1
cyp3a4 inhibitors (1) 1
disease progression (1) 1
double-blind (1) 1
drug resistance, viral (1) 1
drug-resistant hiv-1 (1) 1
ethnic groups (1) 1
experienced hiv-1-infected patients (1) 1
genotype (1) 1
healthy-volunteers (1) 1
hepatitis b - blood (1) 1
hepatitis b - complications (1) 1
hepatitis c - blood (1) 1
hepatitis c - complications (1) 1
hepatitis-c (1) 1
hiv envelope protein gp41 - therapeutic use (1) 1
hiv infections - immunology (1) 1
hiv patients (1) 1
odds ratio (1) 1
peptide fragments - therapeutic use (1) 1
placebo-controlled trial (1) 1
prognostic value (1) 1
receptors, ccr5 - genetics (1) 1
resistant hiv-1 (1) 1
tmc125 etravirine (1) 1
transaminases - blood (1) 1
treatment failure (1) 1
treatment outcome (1) 1
treatment-experienced patients (1) 1
usage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2008, Volume 359, Issue 14, pp. 1429 - 1441
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2008, Volume 359, Issue 14, pp. 1442 - 1455
In key subgroups of the HIV-infected patients in the MOTIVATE 1 and MOTIVATE 2 studies, a consistent treatment benefit of maraviroc over placebo was seen at 48... 
CCR5 ANTAGONIST | MEDICINE, GENERAL & INTERNAL | EFFICACY | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | ACTIVE ANTIRETROVIRAL THERAPY | DRUG-RESISTANT HIV-1 | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | HEPATITIS-C | PROGNOSTIC VALUE | Triazoles - adverse effects | Humans | Middle Aged | Receptors, CCR5 - genetics | Male | RNA, Viral - blood | Hepatitis B - blood | Viral Load | Hepatitis B - complications | Cyclohexanes - therapeutic use | HIV Infections - immunology | Ethnic Groups | HIV Envelope Protein gp41 - therapeutic use | HIV-1 - chemistry | Hepatitis C - blood | Adult | Female | Hepatitis C - complications | Cyclohexanes - adverse effects | Drug Therapy, Combination | Odds Ratio | CCR5 Receptor Antagonists | Triazoles - therapeutic use | Anti-Retroviral Agents - therapeutic use | Double-Blind Method | HIV Infections - virology | Anti-Retroviral Agents - adverse effects | Genotype | Treatment Outcome | CD4 Lymphocyte Count | HIV Fusion Inhibitors - adverse effects | HIV-1 - genetics | HIV Fusion Inhibitors - therapeutic use | HIV Infections - drug therapy | Transaminases - blood | Aged | Peptide Fragments - therapeutic use | Antiviral agents | Care and treatment | Maraviroc | Comparative analysis | Health aspects | HIV infection | Drug therapy | Drug resistance | Human immunodeficiency virus--HIV | Chemokines | Index Medicus | Abridged Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.